co 2 atmosphere (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
96
Structured Review
ATCC
co 2 atmosphere
Co 2 Atmosphere, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 658 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sk+mes+1/SK-MES-1/bio_rxiv__64898__2026__05__19__726276-277-14-25
Average 96 stars, based on 658 article reviews
Co 2 Atmosphere, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 658 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sk+mes+1/SK-MES-1/bio_rxiv__64898__2026__05__19__726276-277-14-25
Average 96 stars, based on 658 article reviews
co 2 atmosphere - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Binding Assay:Article Title: Binding agents binding to PD-L1 and CD137 and use thereof Article Snippet: .. Binding of PD-L1 antibodies and b12xPD-L1 bispecific antibodies to human tumor cell lines MDA-MB-231 (breast adenocarcinoma; ATCC; Cat. no. HTB-26), PC-3 (prostate adenocarcinoma; ATCC; Cat. no. CRL-1435) and Multiple Displacement Amplification:Article Title: Binding agents binding to PD-L1 and CD137 and use thereof Article Snippet: .. Binding of PD-L1 antibodies and b12xPD-L1 bispecific antibodies to human tumor cell lines MDA-MB-231 (breast adenocarcinoma; ATCC; Cat. no. HTB-26), PC-3 (prostate adenocarcinoma; ATCC; Cat. no. CRL-1435) and Flow Cytometry:Article Title: Binding agents binding to PD-L1 and CD137 and use thereof Article Snippet: .. Binding of PD-L1 antibodies and b12xPD-L1 bispecific antibodies to human tumor cell lines MDA-MB-231 (breast adenocarcinoma; ATCC; Cat. no. HTB-26), PC-3 (prostate adenocarcinoma; ATCC; Cat. no. CRL-1435) and Cell Culture:Article Title: HER2-specific synthetic antigen receptor T cell therapy synergizes with radiotherapy to provide improved antitumor efficacy in non-small cell lung cancer Article Snippet: .. Human NSCLC cell lines A549, H1299, H1975, and Article Title: A covalent allosteric molecular glue suppresses NRF2-dependent cancer growth Article Snippet: All cell lines were confirmed 33 negative for mycoplasma and viruses by h-IMPACT1 testing (IDEXX Bioanalytics). .. 34 KYSE70 cells (DSMZ; catalogue no. # ACC363) 35 HCC95 cells (Sigma; catalogue no. # SCC483) 36 VMRC-LCP cells (JCRB; catalogue no. # JCRB0103) 37 NCI-H520 cells (ATCC; catalogue no. # HTB-182) 38 NCI-H1793 cells (ATCC; catalogue no. # CRL-5896) 39 D ow nloaded from http://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.C D -25-1187/3717421/cd-25-1187.pdf by guest on 23 D ecem ber 2025 12 EBC-1 cells (Accegen; catalogue no. # ABL-TC0170) 1 NCI-H1623 cells (ATCC; catalogue no. # CRL-5881) 2 NCI-H2228 (ATCC; catalogue no. # CRL-5935) 3 LK-2 (RIKEN; catalogue no. # RCB1970) 4 NCI-H23 (ATCC; catalogue no.# CRL-5800) 5 KYSE180 (DSMZ; catalogue no.# ACC 379) 6 Article Title: HER2-Specific Synthetic Antigen Receptor (SAR) T Cell Therapy Synergizes with Radiotherapy to Provide Improved Anti-Tumor Efficacy in Non-Small Cell Lung Cancer (NSCLC). Article Snippet: Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints.. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. other:Article Title: Systematic Evaluation Defines the Limits of Ferroptosis in Cancer Therapy Article Snippet: TXNRD1 (SC-28321), GCLC (SC-166345) from Santa Cruz Goat Anti-mouse IgG (H+L), HRP (Invitrogen; 62-6520) Goat Anti-rabbit IgG (H+L), HRP (Invitrogen; 31460). |
![Transformation-induced changes to the protein composition of cell-derived sEVs (A) The morphology of isolated sEVs was assessed using transmission electron microscopy. Images of normal and transformed HBEC-derived sEVs (scale bars, 200 nm). (B) Nanoparticle analysis using tunable resistive pulse sensing of sEVs isolated from HBECs demonstrates that the majority of sEVs have a size range between 30 and 150 nm, and that transformation does not result in an increase in sEV secretion. (C) Western blot of sEVs from HBECs demonstrating the presence of sEV proteins HSP70 and CD63 and the absence of the cell marker calnexin. (D) Label-free mass spectrometry identified 148 proteins with greater abundance in sEVs derived from transformed HBECs (FDR <0.02), of which 15 were annotated as extracellular proteins. (E) Mass spectrometry results were confirmed using ELISA for THBS1, NID1, PTX3, and VCAN in sEVs derived from normal and transformed HBECs. (F) sEVs derived from 22 cancer cell lines including NSCLC <t>(SKMES1,</t> H1650, HCC4006, and H2170), glioblastoma ([GBM], D54, D270, U87, and U118), colorectal cancer ([CRC], HT29 and SW620), breast cancer ([BCa], BT549, MDA231, and MDA436), prostate cancer ([PCa], PC3 and LNCaP), melanoma ([MEL], A375, MAMEL65, and SKMEL28), esophageal cancer ([ECa], OE19), and ovarian cancer ([OVA], A2780, CAOV3, IGROV1, and OVCAR8) showed a clear increase in expression of THBS1, NID1, PTX3, and VCAN in relation to the average levels of sEVs from normal cells ([HBEC] 30KT, HOSE 6.3, and HOSE 17.1). Samples in mass spectrometry and ELISA were measured in triplicate. See also and .](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_0687/pmc13130687/pmc13130687__gr2.jpg)
